Condition: Adenocarcinoma of the Pancreas · Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Prospective multicenter study in which all patients with borderline or locally advanced pancreatic adenocarcioma undergoing neoadjuvant chemotherapy and surgical exploration with curative intent will be included for one year. Preoperative images by traditional CT and 3D-MSP technology will be evaluated, comparing the accuracy variables (sensitivity, specificity, predictive values, area under the curve, concordance index) of both techniques with the gold standard (results of surgery and histopathological analysis).
This description comes directly from the study's public registry record.
Dimitri Dorcaratto · 675441388 · dorcaratto.dimitri@gmail.com
Marina Garcés · marinagarcesalbir@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital General de Alicante | Alicante, Spain | Recruiting |
| Hospital Universitario de Badajoz | Badajoz, Spain | Recruiting |
| Hospital del Mar (Barcelona) | Barcelona, Spain | Recruiting |
| Hospital Clínic de Barcelona | Barcelona, Spain | Recruiting |
| Hospital de Bellvitge | Barcelona, Spain | Recruiting |
| Hospital German Trias y Puyol | Barcelona, Spain | Recruiting |
| Hospital Nuestra señora de la Candelaria | Candelaria, Spain | Recruiting |
| Hospital General de Castellón | Castellon, Spain | Recruiting |
| Hospital Carlos Haya | Málaga, Spain | Recruiting |
| Hospital Virgen de la Victoria | Málaga, Spain | Recruiting |
| Hospital Virgen de la Arrixaca | Murcia, Spain | Recruiting |
| Hospital Son Espases Palma de Mallorca | Palma de Mallorca, Spain | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06582342